These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29788976)

  • 1. Improving the analysis of composite endpoints in rare disease trials.
    McMenamin M; Berglind A; Wason JMS
    Orphanet J Rare Dis; 2018 May; 13(1):81. PubMed ID: 29788976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of responder-based endpoints: improving power through utilising continuous components.
    Wason J; McMenamin M; Dodd S
    Trials; 2020 May; 21(1):427. PubMed ID: 32450909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive clinical trial designs with blinded selection of binary composite endpoints and sample size reassessment.
    Roig MB; Melis GG; Posch M; Koenig F
    Biostatistics; 2023 Dec; 25(1):237-252. PubMed ID: 36150142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the power of clinical trials of rheumatoid arthritis by using data on continuous scales when analysing response rates: an application of the augmented binary method.
    Wason JM; Jenkins M
    Rheumatology (Oxford); 2016 Oct; 55(10):1796-802. PubMed ID: 27338084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A readily available improvement over method of moments for intra-cluster correlation estimation in the context of cluster randomized trials and fitting a GEE-type marginal model for binary outcomes.
    Westgate PM
    Clin Trials; 2019 Feb; 16(1):41-51. PubMed ID: 30295512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new approach for sizing trials with composite binary endpoints using anticipated marginal values and accounting for the correlation between components.
    Bofill Roig M; Gómez Melis G
    Stat Med; 2019 May; 38(11):1935-1956. PubMed ID: 30637797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing power in the analysis of responder endpoints in rheumatology: a software tutorial.
    McMenamin M; Grayling MJ; Berglind A; Wason JMS
    BMC Rheumatol; 2021 Dec; 5(1):54. PubMed ID: 34872620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of confidence interval methods for the intraclass correlation coefficient in community-based cluster randomization trials with a binary outcome.
    Braschel MC; Svec I; Darlington GA; Donner A
    Clin Trials; 2016 Apr; 13(2):180-7. PubMed ID: 26415500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample size determination in clinical trials with multiple co-primary endpoints including mixed continuous and binary variables.
    Sozu T; Sugimoto T; Hamasaki T
    Biom J; 2012 Sep; 54(5):716-29. PubMed ID: 22829198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplicity adjustment for composite binary endpoints.
    Rauch G; Kieser M
    Methods Inf Med; 2012; 51(4):309-17. PubMed ID: 22525969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Composite endpoints, including patient reported outcomes, in rare diseases.
    Verbeeck J; Dirani M; Bauer JW; Hilgers RD; Molenberghs G; Nabbout R
    Orphanet J Rare Dis; 2023 Sep; 18(1):262. PubMed ID: 37658423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small sample performance of bias-corrected sandwich estimators for cluster-randomized trials with binary outcomes.
    Li P; Redden DT
    Stat Med; 2015 Jan; 34(2):281-96. PubMed ID: 25345738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of bias-adjusted generalized estimating equations for sparse binary data in small-sample longitudinal studies.
    Gosho M; Ishii R; Noma H; Maruo K
    Stat Med; 2023 Jul; 42(15):2711-2727. PubMed ID: 37062288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous inference of a binary composite endpoint and its components.
    Große Ruse M; Ritz C; Hothorn LA
    J Biopharm Stat; 2017; 27(1):56-69. PubMed ID: 26881805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small class sizes for improving student achievement in primary and secondary schools: a systematic review.
    Filges T; Sonne-Schmidt CS; Nielsen BCV
    Campbell Syst Rev; 2018; 14(1):1-107. PubMed ID: 37131395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accounting for the rarity of the disease when designing clinical trials with a focus on pediatric cancers.
    Mauguen A
    Clin Trials; 2022 Jun; 19(3):292-296. PubMed ID: 35232288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of composite binary endpoints in clinical trials.
    Bofill Roig M; Gómez Melis G
    Biom J; 2018 Mar; 60(2):246-261. PubMed ID: 29023990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample size determination in clinical trials with multiple co-primary binary endpoints.
    Sozu T; Sugimoto T; Hamasaki T
    Stat Med; 2010 Sep; 29(21):2169-79. PubMed ID: 20687162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Power and sample size calculations for cluster randomized trials with binary outcomes when intracluster correlation coefficients vary by treatment arm.
    Kennedy-Shaffer L; Hughes MD
    Clin Trials; 2022 Feb; 19(1):42-51. PubMed ID: 34879711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.